Non-peptide compound reference

AICAR

AICAR, an analog of adenosine monophosphate, has found clinical application in safeguarding against cardiac ischemia post-heart attack. Its antioxidant attributes make it a potential candidate for retarding the natural aging process. Ongoing investigations explore the potential of AICAR in mitigating the impact of conditions such as diabetes, autoimmune disorders, and various inflammatory ailments.

  • Metabolic research
  • Longevity & mitochondria
Source review pending1 links under reviewEducational context

Dosing literacy

Dosing & scaling, explained

No mass-based amount example with adequate calculation context is available for this compound. This is educational source context—not a protocol or recommendation.

Calculation context

No source-supported amount ladder is shown

Enter a target amount only from your own reviewed source. The calculator can convert it into concentration, volume and device markings, but it will not infer an amount from product availability or another compound.

Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.

Schedule literacy

No independently verified schedule

Evidence context

No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.

Research best practices

Storage, handling and interpretation

Product identity

Verify the exact compound, formulation and amount against the product label or certificate before calculation.

Storage & handling

Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.

Prepared solutions

Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.

Research orientation

What researchers are exploring

These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.

  • 01

    Effects

    AICAR's effects on insulin resistance, inflammation, and cancer research

  • 02

    Anti-inflammatory Properties

    AICAR's role in combating cellular-level inflammation and inflammatory conditions

  • 03

    Research and the Heart

    AICAR's effects on cardiovascular health and atherosclerosis prevention

  • 04

    Research and Fertility

    AICAR's potential effects on sperm motility and fertility research

Evidence map

What is known—and what still needs verification

Available context is organized without assigning unsupported study models or evidence grades.

  • Source review pending

    Effects

    AICAR's effects on insulin resistance, inflammation, and cancer research

  • Source review pending

    Anti-inflammatory Properties

    AICAR's role in combating cellular-level inflammation and inflammatory conditions

Technical reference

Identity, limitations and unknowns

Molecular profile

Sequence
5-aminoimidazole-4-carboxamide ribonucleoside
Molecular Formula
C9H15N4O8P
Molecular Weight
338.213 g/mol
PubChem CID
65110
CAS Number
3031-94-5
Synonyms
AICA ribonucleotide, Z-nucleotide

Important limitations

  • Individual claims and source links have not yet completed editorial verification.
  • Evidence level, applicable study model, formulation, route and population remain unassigned.

Source review

1 links awaiting verification

  1. Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending